Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Int J Radiat Oncol Biol Phys ; 75(2): 455-62, 2009 Oct 01.
Article in English | MEDLINE | ID: mdl-19735868

ABSTRACT

PURPOSE: Radiation-sensitive microcapsules composed of alginate and hyaluronic acid are being developed. We report the development of improved microcapsules that were prepared using calcium- and yttrium-induced polymerization. We previously reported on the combined antitumor effect of carboplatin-containing microcapsules and radiotherapy. METHODS AND MATERIALS: We mixed a 0.1% (wt/vol) solution of hyaluronic acid with a 0.2% alginate solution. Carboplatin (l mg) and indocyanine green (12.5 microg) were added to this mixture, and the resultant material was used for capsule preparation. The capsules were prepared by spraying the material into a mixture containing a 4.34% CaCl(2) solution supplemented with 0-0.01% yttrium. These capsules were irradiated with single doses of 0.5, 1.0, 1.5, or 2 Gy (60)Co gamma-rays. Immediately after irradiation, the frequency of microcapsule decomposition was determined using a microparticle-induced X-ray emission camera. The amount of core content released was estimated by particle-induced X-ray emission and colorimetric analysis with 0.25% indocyanine green. The antitumor effect of the combined therapy was determined by monitoring its effects on the diameter of an inoculated Meth A fibrosarcoma. RESULTS: Microcapsules that had been polymerized using a 4.34% CaCl(2) solution supplemented with 5.0 x 10(-3)% (10(-3)% meant or 10%(-3)) yttrium exhibited the maximal decomposition, and the optimal release of core content occurred after 2-Gy irradiation. The microcapsules exhibited a synergistic antitumor effect combined with 2-Gy irradiation and were associated with reduced adverse effects. CONCLUSION: The results of our study have shown that our liquid core microcapsules can be used in radiotherapy for targeted delivery of chemotherapeutic agents.


Subject(s)
Alginates/chemistry , Antineoplastic Agents/administration & dosage , Capsules/therapeutic use , Carboplatin/administration & dosage , Fibrosarcoma/drug therapy , Hyaluronic Acid/chemistry , Alginates/administration & dosage , Animals , Antineoplastic Agents/adverse effects , Antineoplastic Agents/analysis , Antineoplastic Agents/chemistry , Calcium/analysis , Calcium Chloride/analysis , Calcium Chloride/chemistry , Capsules/adverse effects , Capsules/chemical synthesis , Capsules/radiation effects , Carboplatin/adverse effects , Carboplatin/analysis , Carboplatin/chemistry , Cobalt Radioisotopes/pharmacology , Colorimetry/methods , Combined Modality Therapy/methods , Drug Compounding/methods , Fibrosarcoma/chemically induced , Fibrosarcoma/chemistry , Fibrosarcoma/pathology , Glucuronic Acid/administration & dosage , Glucuronic Acid/chemistry , Hexuronic Acids/administration & dosage , Hexuronic Acids/chemistry , Hyaluronic Acid/administration & dosage , Mice , Mice, Inbred BALB C , Platinum/analysis , Polymers , Time Factors , Yttrium/administration & dosage , Yttrium/pharmacology
2.
Nihon Jinzo Gakkai Shi ; 47(7): 828-33, 2005.
Article in Japanese | MEDLINE | ID: mdl-16296413

ABSTRACT

Herein we describe the case of a patient with focal segmental glomerulosclerosis (FSGS) following polycythemia vera (PV) on whom hemodialysis was started 7 years later. A 66-year-old woman who had been treated for PV with hydroxyurea and phlebotomy for three years was referred to our hospital because of nephrotic syndrome. Renal biopsy performed at her local hospital revealed FSGS. Although she had received prednisolone at an initial dose of 45 mg/day, no significant improvement of proteinuria was achieved. The dose of prednisolone was tapered because the second renal biopsy revealed sclerosing glomerulopathy. We considered that FSGS was associated with PV because renal hemodynamic alterations in PV could result in FSGS as in any other secondary FSGS and there was no proteinuria at the initial detection of PV. On January 29, 1999, she developed massive proteinuria (9.6 g/day) and the findings of the third renal biopsy worsened in comparison with that of the first renal biopsy. Thereafter, hydroxyurea or ranimustine was used in treating PV at an outpatient clinic. However severe thrombocytosis was difficult to control, and progressive renal dysfunction finally necessitated hemodialysis on January 18, 2005. In conclusion, physicians should be aware of the risk of progressive renal failure in patients with FSGS following PV, particularly in patients with persistent thrombocytosis.


Subject(s)
Glomerulosclerosis, Focal Segmental/etiology , Glomerulosclerosis, Focal Segmental/therapy , Polycythemia Vera/complications , Renal Dialysis , Aged , Disease Progression , Female , Glomerulosclerosis, Focal Segmental/pathology , Humans , Hydroxyurea/therapeutic use , Nitrosourea Compounds/therapeutic use , Phlebotomy , Polycythemia Vera/therapy , Proteinuria/etiology , Thrombocytosis/complications
3.
Clin Exp Nephrol ; 9(3): 252-4, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16189636

ABSTRACT

We describe the case of a patient who developed microscopic polyangiitis (MPA) after silicone breast implantation. A 60-year-old woman who had undergone silicone breast implantation was admitted to our hospital with complaints of general malaise and hematoproteinuria. She was diagnosed as having MPA with evidence of acute progressive renal failure, pulmonary hemorrhage, and positivity for myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA). A renal biopsy showed severe necrotizing and crescentic glomerulonephritis with arteriolitis. The patient received high-dose steroids and plasma exchange treatment, but died of progressive pulmonary hemorrhage and multiple cerebral hemorrhage. Silicone implantation is associated with scleroderma, systemic lupus erythematosus, and rheumatoid arthritis. This case report indicates the possibility of the development of MPA after silicone breast implantation.


Subject(s)
Acute Kidney Injury/etiology , Breast Implantation/adverse effects , Vasculitis/etiology , Fatal Outcome , Female , Glomerulonephritis/etiology , Glomerulonephritis/pathology , Humans , Middle Aged , Silicone Gels , Vasculitis/pathology
4.
Nippon Ganka Gakkai Zasshi ; 108(10): 606-11, 2004 Oct.
Article in Japanese | MEDLINE | ID: mdl-15559313

ABSTRACT

PURPOSE: We investigated seasonal allergic conjunctivitis in Hakodate. MATERIALS AND METHODS: The clinical records of 293 patients with allergy-like symptoms who were seen at the Departments of Ophthalmology and Otolaryngology of Hakodate Municipal Hospital in 2001 and 2002 were examined for pollinosis, and evaluated. The general severity of conjunctivitis was graded as (+), (++), and (+++). The allergen was identified by AlaSTAT and nasal provocation test. RESULTS: In March, June, and September 2001, and in March, April, and June 2002, many patients were examined. In 2001, 134 patients (87.0%) had allergic conjunctivitis, and 126 patients (90.6%) had it in 2002. The severity of allergic conjunctivitis in May, June, and September was significantly (p<0.05) more severe than in February, March, and April. The major antigen rates for Cryptomeria japonica, Gramineae, Artemisia, and Betula platyphyia var. japonica were 22, 21, 8, and 3%. The specific IgE positive rates for Cryptomeria japonica, Betula platyphyia var. japonica, Gramineae and Artemisia were higher in March and April, in May, in June, and in September. CONCLUSION: The allergens of conjunctivitis in Hakodate were not the same as in the Kansai. We should consider the dispersion of pollens area by area.


Subject(s)
Conjunctivitis, Allergic/epidemiology , Conjunctivitis, Allergic/immunology , Seasons , Adolescent , Adult , Aged , Aged, 80 and over , Allergens/immunology , Child , Child, Preschool , Conjunctivitis, Allergic/diagnosis , Female , Humans , Immunoglobulin E/blood , Japan/epidemiology , Male , Middle Aged , Pollen/immunology , Severity of Illness Index , Trees
SELECTION OF CITATIONS
SEARCH DETAIL
...